Autori: Calabresi PA
| Naslov | Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial. (Meeting Abstract) |
| Autori | Cadaviv Diego Edwards KR Hupperts Raymond Drulovic Jelena S Montalban Xavier Hartung H-P Brochet B Calabresi PA Rudick R Ibrahim Adama Zhang Yiwei Xu Lei |
| Info | MULTIPLE SCLEROSIS JOURNAL, (2016), vol. 22 br. , Suppl. 3, str. 66-66 |
| Projekat | Biogen (Cambridge, MA, USA); Actelion; Biogen; Eisai; Eli Lilly; Forum Pharmaceuticals; Genentech; Genzyme/Sanofi; Hoffman-La Roche; Merz Pharmaceuticals; Novartis; Pfizer; Vaccinex; Merck Serono; Ministry of Education and Science, Republic of Serbia [175 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
